We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biovail, GSK Want Wellbutrin Antitrust Suit Tossed

Law360 (May 1, 2009, 12:00 AM EDT) -- Biovail Corp. and SmithKline Beecham Corp. have moved to dismiss a consolidated class action complaint against them by indirect purchasers of Wellbutrin XL alleging the drug companies illegally monopolized the market...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.